Clinical Virology

Press Release

9 Feb 2012

PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced the expansion of its executive management team with the appointments of Nima Farzan as Executive Vice President and Chief Operating Officer, Thomas P. Monath, M.D. as Chief Technology Officer, and Jonathan F. Smith, Ph.D. as Executive Vice President and Chief Scientific ...

PaxVax Expands Executive Management Team

9 Feb 2012

PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced the expansion of its executive management team with the appointments of Nima Farzan as Executive Vice President and Chief Operating Officer, Thomas P.

Flu Season Atypical In New Jersey

8 Feb 2012

In New Jersey, state officials say influenza activity is low in the south and moderate in the north.